[Anatomical Lung Resection Following Neoadjuvant Chemoimmunotherapy: Technical Aspects and Case Reports]

Martin Eichhorn1,2, Florian Eichhorn1,2, Raffaella Griffo1

  • 1Chirurgische Abteilung, Thoraxklinik, Universitätsklinikum Heidelberg, Heidelberg, Deutschland.

PubMed
Summary

Neoadjuvant chemo-immunotherapy improves treatment for non-small cell lung cancer (NSCLC). This review examines perioperative safety, surgical techniques, and challenges after this therapy for resectable NSCLC.

Related Concept Videos